Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)

v3.24.3
BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)
9 Months Ended
Sep. 30, 2024
USD ($)
Integer
U.S. Patents owned by the company 104
Expired patents 54
Foreign patents owned by the company 16
ILiAD Biotechnologies, LLC [Member]  
Aggregate investment amount | $ $ 7,000,000